Cell cycle regulators and their abnormalities in breast cancer.
AUTOR(ES)
Fernández, P L
RESUMO
One of the main properties of cancer cells is their increased and deregulated proliferative activity. It is now well known that abnormalities in many positive and negative modulators of the cell cycle are frequent in many cancer types, including breast carcinomas. Abnormalities such as defective function of the retinoblastoma gene and cyclin-dependent kinase inhibitors (for example, p16, p21, and p27), as well as upregulation of cyclins, are often seen in breast tumours. These abnormalities are sometimes coincidental, and newly described interplays between them suggest the existence of a complex regulatory web in the cell cycle.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=395656Documentos Relacionados
- Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
- Computed cell cycle and DNA histogram analyses in image cytometry in breast cancer.
- Signal transduction abnormalities in cancer mitogen-activated protein kinase regulation is altered in breast cancer.
- Balancing cell life and death: bax, apoptosis, and breast cancer.
- Oral contraceptives and breast cancer.